“We are entering this next stage as our FDA-cleared portfolio continues to expand to support broader cardiac imaging workflows,” said Davidi Vortman, the company’s CEO and co-founder. | Read More in JPost.com – Business & Innovation | The Jerusalem Post. in Israel NOWlej.
